Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Tag: Lancet Rheumatology

Press Review…

Winter 2026 Press Review – The Lancet Rheumatology

18 Jan 2026
August 2025 to November 2025 Author: Nikolaos Vlachogiannis Effectiveness of treat-to-target tapering of TNF inhibitors in spondyloarthritides: a 24-month follow-up study Amy C D Peeters et al. (10.1016/s2665-9913(25)00070-0) examined whether a…
Press Review…

Autumn 2025 Press Review – Arthritis Research & Therapy

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Clementina López-Medina Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster Curtis…
Press Review…

Autumn 2025 Press Review – The Lancet Rheumatology

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Clementina López-Medina Baricitinib in early polymyalgia rheumatic (BACHELOR): a randomised, double-blind, placebo-controlled, parallel group trial Saraux A, et al. (10.1016/S2665-9913(24)00270-4) aimed to test whether baricitinib…
Press Review…

Spring 2025 Press Review – Lancet Rheumatology

12 May 2025
December 2024 to March 2025 Author: Antony Psarras and Rositsa Dacheva Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised,…
Press Review…

Winter 2025 Press Review – Lancet Rheumatology

2 Feb 2025
August 2024 to November 2024 Authors: Halbert Hernández Negrin and Magda Osipyan Nirmatrelvir–Ritonavir Reduces Mortality and Sequelae in Immunocompromised COVID-19 Patients Lin et al. (10.1016/S2665-9913(24)00224-8) investigated the impact of nirmatrelvir–ritonavir…
Press Review…

Autumn 2024 Press Review – Lancet Rheumatology

8 Oct 20249 Oct 2024
April 2024 to July 2024 Author: Olivier Fakih & Roba Ghossan Lancet Rheumatology Identification of distinct subgroups of Sjögren's disease by cluster analysis Nguyen et al. (10.1016/S2665-9913(23)00340-5) aimed to identify distinct…
The Lancet Rheumatology

Spring 2024 Press Review – Lancet Rheumatology

9 May 202410 May 2024
December 2023 to March 2024 Author: Emre Bilgin & Rudi Shukla Lancet Rheumatology Saraux et al (doi:10.1016/S2665-9913(23)00246-1) investigated whether abatacept has a role in the management of early polymyalgia rheumatica (PMR). In this proof-of-concept,…

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify
 

Loading Comments...